ELI LILLY monoclonal antibody treatment for COVID Shows Promise

the staff of the Ridgewood blog Ridgewood NJ, according to Johns Hopkins Center for Health Security , ELI LILLY A recent study published in the New England Journal of Medicine last week reported that convalescent plasma derived monoclonal antibody treatment (LY-CoV555), developed by Eli Lilly, showed clinical benefit in patients. The study found that patients experienced decreased viral … Continue reading ELI LILLY monoclonal antibody treatment for COVID Shows Promise